ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL2945 |
|
305350-87-2 |
SL 327 98+% |
C16H12F3N3S | |
HL1760 |
|
526-07-8 |
Sesamolin 98+% |
C20H18O7 | |
HL1732 |
|
240423-23-8 |
Salvicine 98+% |
C20H26O4 | |
CL2932 |
|
271576-80-8 |
SD-06 | SD-0006 98+% |
C20H20ClN5O2 | |
CL2914 |
|
193551-21-2 |
SB-239063 98+% |
C20H21FN4O2 | |
CL2908 |
|
152121-53-4 |
PD 169316 98+% |
C20H13FN4O2 | |
CL2898 |
|
303162-79-0 |
TAK-715 98+% |
C24H21N3OS | |
CL2830 |
|
2729996-45-4 |
GNE-9815 98+% |
C26H22FN5O2 | |
HL1531 |
|
511-05-7 |
Sugiol | (+)-Sugiol | 10-Deoxoxanthoperol 98+% |
C20H28O2 | |
CL2747 |
|
1448428-04-3 |
Selonsertib | GS-4997 | Selonsertib (free base) 98+% |
C24H24FN7O | |
CL2728 |
|
152121-30-7 |
SB 202190 | FHPI 98+% |
C20H14 FN3O | |
CL2485 |
|
212631-79-3 |
PD184352(CI-1040) 98+% |
C17H14ClF2 IN2O2 | |
CL2469 |
|
309913-42-6 |
SX 011/SX-011 98+% |
C26H27ClFN3O3 | |
CL2095 |
|
918504-65-1 |
Vemurafenib (PLX 4032) 98+% |
C23H18ClF2N3O3S | |
CL1287 |
|
934660-93-2 |
Cobimetinib (GDC-0973; XL518) 98+% |
C21H21F3IN3O2 | |
CL1076 |
|
284461-73-0 |
Sorafenib; BAY 43-9006; Sorafenib Base; Sorafenib Free Base 98+% |
C21H16ClF3N4O3 | |
CL1077 |
|
391210-10-9 |
Mirdametinib (PD0325901) 99+% |
C16H14F3IN2O4 | |
CL1076A |
|
475207-59-1 |
Sorafenib Tosylate 99+% |
C28H24ClF3N4O6S | |
CL1853 |
|
152121-47-6 |
Adezmapimod |SB 203580 | RWJ 64809 | PB 203580 98+% |
C21H16FN3OS | |
CL1853A |
|
869185-85-3 |
Adezmapimod Hydrochloride | SB 203580 Hydrochloride | RWJ 64809 Hydrochloride 98+% |
C21H17ClFN3OS | |